Chemogenetic modulation of catecholaminergic neurons

Output Details

This protocol outlines a method for modulating noradrenergic and dopaminergic neuronal activity in the LC and SNc-VTA, respectively, using Cre-dependent hM3D and hM4D expression. It details stereotactic injection techniques for these chemogenetic tools and the preparation of the J60 agonist for intraperitoneal delivery. Developed for longitudinal studies spanning up to four weeks, the protocol aims to assess neuromelanin's activity-dependent accumulation through daily agonist administration.
Tags
  • Animal

Meet the Authors

  • User avatar fallback logo

    Cristian Gonzalez-Cabrera, PhD

    Key Personnel: Team Vila

    Leibniz Institute for Neurobiology

  • Csilla Novák, MSc

    Key Personnel: Team Vila

    Leibniz Institute for Neurobiology

  • User avatar fallback logo

    Maria Paz Contreras Santander, MD, PhD

    Key Personnel: Team Vila

    Leibniz Institute for Neurobiology

  • User avatar fallback logo

    Ernesto Durán, PhD

    Key Personnel: Team Vila

    Leibniz Institute for Neurobiology

  • Matthias Prigge, PhD

    Co-PI (Core Leadership): Team Vila

    Leibniz Institute for Neurobiolog